Online first
Original article
Published online: 2025-03-07
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation
Pubmed: 40066955
Abstract
Background: This study evaluates the association between left and right atrial (LA, RA) parameters and a composite endpoint (CEP) of all-cause death, thromboembolism, acute coronary syndrome, and heart failure hospitalization in atrial fibrillation patients.
Methods: Patients were prospectively enrolled. At baseline, the following echocardiogram parameters were measured: LA and RA antero-posterior diameter indexed (iLAAPD, iRAAPD), LA and RA volume indexed (LAVi, RAVi), LA and RA sphericity index (LASI, RASI), LA and RA emptying fraction.
Results: A total of 489 patients (61.3% males) with a median age of 75 (66–80) years and a median CHA2DS2VASc score of 3 (2–5) were enrolled (92.2% receiving anticoagulation). Permanent atrial fibrillation was present in 40.5% of the total cohort. After a median follow-up of 1114 (392–1384) days, 129 patients (26.3%) reached the CEP. The highest sensitivity for CEP was for LA emptying fraction <28% and iRAAPD >24 mm/m2 (72% and 73%, respectively) while the best negative predictive values were for iLAAPD and LAVi (both 81%). Right atrial parameters were not associated with CEP. Discrimination analysis using net reclassification improvement (NRI) showed that iLAAPD, and LAVi significantly improved patient reclassification compared to a null model without atrial parameters (iLAAPD NRI 0.30; P = 0.005; LAVi NRI 0.32; P = 0.002). Multivariable Cox regression analysis found that LA dimensions, volume, and function were associated with a higher risk of adverse outcomes and significantly improved risk prediction for the CEP.
Conclusions: LAVi and iLAAPD enhance discrimination and risk prediction for adverse outcomes in AF patients.
Keywords: atrial cardiomyopathyatrial fibrillationatrial remodelingechocardiographyoutcome
References
- Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024; 45(36): 3314–3414.
- Boriani G, Vitolo M, Diemberger I, et al. Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes. Cardiovasc Res. 2021; 117(7): 1–21.
- Goette A, Kalman J, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Europace. 2016; 18(10): 1455–1490.
- Deneke T, Kutyifa V, Hindricks G, et al. Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the European Society of Cardiology. Europace. 2024; 26(5): euae108.
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015; 16(3): 233–270.
- Malavasi VL, Fantecchi E, Tordoni V, et al. Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. Intern Emerg Med. 2021; 16(5): 1131–1140.
- D'Ascenzo F, Corleto A, Biondi-Zoccai G, et al. Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: A meta-analysis. Int J Cardiol. 2013; 167(5): 1984–1989.
- Zhuang J, Wang Y, Tang K, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace. 2012; 14(5): 638–645.
- Choi SH, Yu HT, Kim D, et al. Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome. Europace. 2023; 25(5): euad113.
- Charitakis E, Dragioti E, Stratinaki M, et al. Predictors of recurrence after catheter ablation and electrical cardioversion of atrial fibrillation: An umbrella review of meta-analyses. Europace. 2023; 25(1): 40–48.
- Schaaf M, Andre P, Altman M, et al. Left atrial remodelling assessed by 2D and 3D echocardiography identifies paroxysmal atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2017; 18(1): 46–53.
- Ma XX, Boldt LH, Zhang YL, et al. Clinical relevance of left atrial strain to predict recurrence of atrial fibrillation after catheter ablation: A meta-analysis. Echocardiography. 2016; 33(5): 724–733.
- Marchandise S, Garnir Q, Scavée C, et al. Prediction of left atrial fibrosis and success of catheter ablation by speckle tracking echocardiography in patients imaged in persistent atrial fibrillation. Front Cardiovasc Med. 2022; 9: 856796.
- Jasic-Szpak E, Marwick TH, Donal E, et al. Prediction of AF in heart failure with preserved ejection fraction: Incremental value of left atrial strain. JACC Cardiovasc Imaging. 2021; 14(1): 131–144.
- Mannina C, Ito K, Jin Z, et al. Association of left atrial strain with ischemic stroke risk in older adults. JAMA Cardiol. 2023; 8(4): 317–325.
- Gunturiz-Beltrán C, Nuñez-Garcia M, Althoff TF, et al. Progressive and simultaneous right and left atrial remodeling uncovered by a comprehensive magnetic resonance assessment in atrial fibrillation. J Am Heart Assoc. 2022; 11(20): e026028.
- Imberti JF, Mei DA, Vitolo M, et al. Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations. Eur J Intern Med. 2022; 101: 1–7.
- Mei DA, Imberti JF, Bonini N, et al. Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry. Eur J Intern Med. 2024; 128: 63–70.
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 1–39.e14.
- Blume GG, Mcleod CJ, Barnes ME, et al. Left atrial function: Physiology, assessment, and clinical implications. Eur J Echocardiogr. 2011; 12(6): 421–430.
- Barbieri A, Bursi F, Zanasi V, et al. Left atrium reclassified: application of the American Society of Echocardiography/European Society of Cardiology cutoffs to unselected outpatients referred to the echocardiography laboratory. J Am Soc Echocardiogr. 2008; 21(5): 433–438.
- DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988; 44(3): 837–845.
- Pencina MJ, D'Agostino RB, D'Agostino RB, et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med. 2008; 27(2): 157–172; discussion 207–212.
- Gauthier J, Wu QV, Gooley TA. Cubic splines to model relationships between continuous variables and outcomes: A guide for clinicians. Bone Marrow Transplant. 2020; 55(4): 675–680.
- Galderisi M, Donal E, Magne J, et al. Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2018; 19(3): 245–252.
- Guichard JB, Nattel S. Atrial cardiomyopathy: A useful notion in cardiac disease management or a passing fad? J Am Coll Cardiol. 2017; 70(6): 756–765.
- Vitolo M, Proietti M, Imberti JF, et al. Factors associated with progression of atrial fibrillation and impact on all-cause mortality in a cohort of European patients. J Clin Med. 2023; 12(3): 768.
- Boriani G, Vitolo M, Imberti JF. The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy. Eur J Intern Med. 2022; 101: 34–36.
- Tufano A, Lancellotti P. Atrial cardiomyopathy: Pathophysiology and clinical implications. Eur J Intern Med. 2022; 101: 29–31.
- Stalikas N, Doundoulakis I, Karagiannidis E, et al. Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: A systematic review. Eur J Intern Med. 2022; 99: 38–44.
- Boriani G, Gerra L, Mantovani M, et al. Atrial cardiomyopathy: An entity of emerging interest in the clinical setting. Eur J Intern Med. 2023; 118: 14–21.
- Tsang TSM, Abhayaratna WP, Barnes ME, et al. Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter? J Am Coll Cardiol. 2006; 47(5): 1018–1023.
- Goette A, Corradi D, Dobrev D, et al. Atrial cardiomyopathy revisited-evolution of a concept: A clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2024; 26(9): euae204.
- Kishima H, Mine T, Takahashi S, et al. Left atrial ejection force predicts the outcome after catheter ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2018; 29(2): 264–271.
- Manning WJ, Silverman DI, Katz SE, et al. Atrial ejection force: A noninvasive assessment of atrial systolic function. J Am Coll Cardiol. 1993; 22(1): 221–225.
- Boriani G, Vitolo M, Imberti JF. Atrial cardiomyopathy: A derangement in atrial volumes, geometry, function, and pathology with important clinical implications. J Cardiovasc Med (Hagerstown). 2022; 23(6): 359–362.
- Schnabel RB, Marinelli EA, Arbelo E, et al. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: The 8th AFNET/EHRA consensus conference. Europace. 2023; 25(1): 6–27.
- Inoue K, Smiseth OA. Left atrium as key player and essential biomarker in heart failure. J Cardiol. 2025; 85(1): 8–16.
- Sun ZY, Li Q, Li J, et al. Echocardiographic evaluation of the right atrial size and function: Relevance for clinical practice. Am Heart J Plus. 2023; 27: 100274.
- Prabhu S, Voskoboinik A, McLellan AJA, et al. A comparison of the electrophysiologic and electroanatomic characteristics between the right and left atrium in persistent atrial fibrillation: Is the right atrium a window into the left? J Cardiovasc Electrophysiol. 2017; 28(10): 1109–1116.
- Ko KY, Jang JH, Choi SH, et al. Impact of right atrial enlargement on clinical outcome in patients with atrial fibrillation. Front Cardiovasc Med. 2022; 9: 989012.
- Di Biase L, Zou F, Lin AN, et al. Feasibility of three-dimensional artificial intelligence algorithm integration with intracardiac echocardiography for left atrial imaging during atrial fibrillation catheter ablation. Europace. 2023; 25(9): euad211.
- Matei LL, Popescu RM, Popescu AC, et al. Early echocardiographic predictors for atrial fibrillation propensity: The left atrium oracle. Rev Cardiovasc Med. 2022; 23(6): 205.
- Mandoli GE, Cameli M, Pastore MC, et al. Speckle tracking echocardiography in early disease stages: a therapy modifier? J Cardiovasc Med (Hagerstown). 2023; 24(Suppl 1): e55–e66.
- Jing M, Li D, Xi H, et al. Value of imaging in the non-invasive prediction of recurrence after catheter ablation in patients with atrial fibrillation: An up-to-date review. Rev Cardiovasc Med. 2023; 24(8): 241.
- Russo C, Jin Z, Homma S, et al. LA phasic volumes and reservoir function in the elderly by real-time 3D echocardiography: Normal values, prognostic significance, and clinical correlates. JACC Cardiovasc Imaging. 2017; 10(9): 976–985.
- Vera A, Cecconi A, Ximénez-Carrillo Á, et al. Advanced echocardiography with left atrial strain and indexed left atrial three-dimensional volume for predicting underlying atrial fibrillation after cryptogenic stroke. Am J Cardiol. 2022; 185: 87–93.
- Hsu PC, Lee WH, Chu CY, et al. Prognostic role of left atrial strain and its combination index with transmitral E-wave velocity in patients with atrial fibrillation. Sci Rep. 2016; 6: 17318.
- Obokata M, Negishi K, Kurosawa K, et al. Left atrial strain provides incremental value for embolism risk stratification over CHA₂DS₂-VASc score and indicates prognostic impact in patients with atrial fibrillation. J Am Soc Echocardiogr. 2014; 27(7): 709–716.e4.
